Company / Total Debt
GeneDx Holdings Corp. Total Debt History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$54.5M
FY2025
5-year range
$11.0M / $56.3M
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#92 of 102
Health Care
What the data says
Among 102 Health Care companies, GeneDx Holdings Corp. is in the top 10% for total debt. Improved from $56M to $55M over the past 2 years.
Based on SEC 10-K filings.
$55M in FY2025 with a 5-year CAGR of +23.5%.
Improved from $56M to $55M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +70.5%
- 5-Year CAGR
- +23.5%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 102This company $54.5M Sector average $4.5B
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.5%, indicating consistent growth.
- In FY2025, total debt decreased 2.2% year-over-year.
- Ranks #92 out of 102 companies in the Health Care sector.
- Peak total debt was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.5M | -2.2% |
| FY2024 | $55.8M | -0.9% |
| FY2023 | $56.3M | +411.4% |
| FY2022 | $11.0M | +0.0% |
| FY2021 | $11.0M | -42.0% |
| FY2020 | $19.0M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026